Global Erythromelalgia Treatment Market By Region
| Label | Gabapentin | Others | Pregabalin |
|---|---|---|---|
| 2019 | 1.2551 USD Million | 0.593 USD Million | 1.1057 USD Million |
| 2020 | 1.1728 USD Million | 0.54 USD Million | 1.0297 USD Million |
| 2021 | 1.226 USD Million | 0.5497 USD Million | 1.0727 USD Million |
| 2022 | 1.2921 USD Million | 0.5639 USD Million | 1.1266 USD Million |
| 2023 | 1.3655 USD Million | 0.5798 USD Million | 1.1865 USD Million |
| 2024 | 1.4492 USD Million | 0.5988 USD Million | 1.2552 USD Million |
| 2025 | 1.5384 USD Million | 0.6179 USD Million | 1.3279 USD Million |
| 2026 | 1.6362 USD Million | 0.6393 USD Million | 1.4079 USD Million |
| 2027 | 1.7445 USD Million | 0.6622 USD Million | 1.4962 USD Million |
| 2028 | 1.8645 USD Million | 0.6872 USD Million | 1.5939 USD Million |
| 2029 | 1.9976 USD Million | 0.7146 USD Million | 1.7022 USD Million |
| 2030 | 2.1458 USD Million | 0.7446 USD Million | 1.8227 USD Million |
| 2031 | 2.3111 USD Million | 0.7774 USD Million | 1.9568 USD Million |
| 2032 | 2.496 USD Million | 0.8135 USD Million | 2.1067 USD Million |
| 2033 | 2.7034 USD Million | 0.8531 USD Million | 2.2747 USD Million |
| 2034 | 2.9366 USD Million | 0.8967 USD Million | 2.4633 USD Million |
| 2035 | 3.1999 USD Million | 0.9448 USD Million | 2.6759 USD Million |
Data Source: Wantstats Repository
Growth Outlook
- The Global Erythromelalgia Treatment Market By Anticonvulsants market is on a steady long-term growth path. Segment value stands at roughly USD 4 Million in 2026 and is projected to reach USD 7 Million by 2035 — a gain of about 85% over the forecast period, translating to a CAGR in the high single digits.
- What the regional split looks like (2026): Gabapentin leads, holding roughly 44% of segment value — the single largest regional share. Pregabalin is the second-largest contributor. Others make up the remainder, in descending order.
- By 2035, Gabapentin alone is expected to reach USD 3 Million, with Pregabalin at USD 3 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
USD49
Buy NowPowering the world's best teams.
From next-gen startups to established enterprises.
Contact us
Get in Touch
Let's work together
support@wantstats.comWantstats Research and Media Pvt. Ltd., Office No 104, Pentagon 4, Magarpatta City, Pune - 411028, Maharashtra, India.
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



